• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞激活和肝纤维化中的机械稳态失衡

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis.

作者信息

Zhao Yuan-Quan, Deng Xi-Wen, Xu Guo-Qi, Lin Jie, Lu Hua-Ze, Chen Jie

机构信息

Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.

Graduate School of Youjiang Medical University for Nationalities, Baise, China.

出版信息

Front Mol Biosci. 2023 Apr 20;10:1183808. doi: 10.3389/fmolb.2023.1183808. eCollection 2023.

DOI:10.3389/fmolb.2023.1183808
PMID:37152902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10157180/
Abstract

Chronic liver disease or repeated damage to hepatocytes can give rise to hepatic fibrosis. Hepatic fibrosis (HF) is a pathological process of excessive sedimentation of extracellular matrix (ECM) proteins such as collagens, glycoproteins, and proteoglycans (PGs) in the hepatic parenchyma. Changes in the composition of the ECM lead to the stiffness of the matrix that destroys its inherent mechanical homeostasis, and a mechanical homeostasis imbalance activates hepatic stellate cells (HSCs) into myofibroblasts, which can overproliferate and secrete large amounts of ECM proteins. Excessive ECM proteins are gradually deposited in the Disse gap, and matrix regeneration fails, which further leads to changes in ECM components and an increase in stiffness, forming a vicious cycle. These processes promote the occurrence and development of hepatic fibrosis. In this review, the dynamic process of ECM remodeling of HF and the activation of HSCs into mechanotransduction signaling pathways for myofibroblasts to participate in HF are discussed. These mechanotransduction signaling pathways may have potential therapeutic targets for repairing or reversing fibrosis.

摘要

慢性肝病或肝细胞反复受损可导致肝纤维化。肝纤维化(HF)是细胞外基质(ECM)蛋白如胶原蛋白、糖蛋白和蛋白聚糖(PGs)在肝实质中过度沉积的病理过程。ECM组成的变化导致基质僵硬,破坏其固有的机械稳态,而机械稳态失衡会激活肝星状细胞(HSCs)转化为肌成纤维细胞,肌成纤维细胞会过度增殖并分泌大量ECM蛋白。过量的ECM蛋白逐渐沉积在狄氏间隙,基质再生失败,这进一步导致ECM成分改变和硬度增加,形成恶性循环。这些过程促进了肝纤维化的发生和发展。在本综述中,讨论了HF的ECM重塑动态过程以及HSCs激活为肌成纤维细胞参与HF的机械转导信号通路。这些机械转导信号通路可能具有修复或逆转纤维化的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f1/10157180/e3366ab36573/fmolb-10-1183808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f1/10157180/c47f9774ae1e/fmolb-10-1183808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f1/10157180/e3366ab36573/fmolb-10-1183808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f1/10157180/c47f9774ae1e/fmolb-10-1183808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f1/10157180/e3366ab36573/fmolb-10-1183808-g002.jpg

相似文献

1
Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis.肝星状细胞激活和肝纤维化中的机械稳态失衡
Front Mol Biosci. 2023 Apr 20;10:1183808. doi: 10.3389/fmolb.2023.1183808. eCollection 2023.
2
Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis.基质力学作为肝纤维化的调控因子和治疗靶点。
Int J Biol Sci. 2019 Sep 7;15(12):2509-2521. doi: 10.7150/ijbs.37500. eCollection 2019.
3
Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.胶原酶 I 修饰的共递送胶束增强细胞外基质降解和肝星状细胞靶向治疗肝纤维化。
Acta Biomater. 2022 Oct 15;152:235-254. doi: 10.1016/j.actbio.2022.08.065. Epub 2022 Sep 8.
4
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease.肝病中基质硬度的调节因子、功能及机械转导途径
Front Physiol. 2023 Jan 12;14:1098129. doi: 10.3389/fphys.2023.1098129. eCollection 2023.
5
New Perspectives on Chinese Medicine in Treating Hepatic Fibrosis: Lipid Droplets in Hepatic Stellate Cells.从新视角看中药治疗肝纤维化:肝星状细胞中的脂滴。
Am J Chin Med. 2023;51(6):1413-1429. doi: 10.1142/S0192415X23500647. Epub 2023 Jul 10.
6
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
7
[Hepatic stellate cells: it's role in normal and pathological conditions].[肝星状细胞:其在正常及病理状态下的作用]
Gastroenterol Hepatol. 2006 Feb;29(2):93-101. doi: 10.1157/13083906.
8
In Situ Regulation and Mechanisms of 3D Matrix Stiffness on the Activation and Reversion of Hepatic Stellate Cells.三维基质硬度对肝星状细胞激活和逆转的原位调控及机制
Adv Healthc Mater. 2023 Apr;12(9):e2202560. doi: 10.1002/adhm.202202560. Epub 2022 Dec 23.
9
The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.NADPH氧化酶(NOXs)在肝纤维化及肌成纤维细胞激活中的作用
Front Physiol. 2016 Feb 2;7:17. doi: 10.3389/fphys.2016.00017. eCollection 2016.
10
Hepatic Stellate Cell: A Double-Edged Sword in the Liver.肝星状细胞:肝脏中的双刃剑。
Physiol Res. 2021 Dec 30;70(6):821-829. doi: 10.33549/physiolres.934755. Epub 2021 Oct 30.

引用本文的文献

1
Overexpression miR-125a-5p inhibits HSCs activation and alleviates liver fibrosis through TGF-β/Smad2/3 signaling pathway and autophagy.miR-125a-5p过表达通过TGF-β/Smad2/3信号通路和自噬抑制肝星状细胞激活并减轻肝纤维化。
Cell Death Discov. 2025 Sep 1;11(1):419. doi: 10.1038/s41420-025-02694-4.
2
Repurposing GLP-1 Receptor Agonists: A Perspective on Epigenetic Strategies to Combat Fibrosis and Hepatocellular Carcinoma in the Aged Liver.重新利用胰高血糖素样肽-1受体激动剂:对抗老年肝脏纤维化和肝细胞癌的表观遗传策略展望。
Cancers (Basel). 2025 Aug 8;17(16):2600. doi: 10.3390/cancers17162600.
3
Activation of the Wnt signaling pathway and its role in epithelial-mesenchymal transition and hepatic fibrosis in alveolar echinococcosis.

本文引用的文献

1
Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.基质金属蛋白酶通过多种途径诱导细胞外基质降解,从而减轻肝纤维化。
Biomed Pharmacother. 2023 May;161:114472. doi: 10.1016/j.biopha.2023.114472. Epub 2023 Mar 2.
2
Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets.透明质酸在肝纤维化中的作用:基础机制、临床意义和治疗靶点。
Hepatol Commun. 2023 Mar 17;7(4). doi: 10.1097/HC9.0000000000000083. eCollection 2023 Apr 1.
3
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells.
Wnt信号通路的激活及其在泡型棘球蚴病上皮-间质转化和肝纤维化中的作用
Front Cell Infect Microbiol. 2025 May 27;15:1583802. doi: 10.3389/fcimb.2025.1583802. eCollection 2025.
4
Mechanotransduction in Development: A Focus on Angiogenesis.发育过程中的机械转导:聚焦于血管生成
Biology (Basel). 2025 Mar 27;14(4):346. doi: 10.3390/biology14040346.
5
Investigating the role of Wnt3a and Wnt5a as critical factors of hepatic stellate cell activation in acute toxicant-induced liver injury.研究Wnt3a和Wnt5a作为急性毒物诱导肝损伤中肝星状细胞激活关键因子的作用。
Cell Biol Toxicol. 2024 Dec 21;41(1):5. doi: 10.1007/s10565-024-09956-4.
6
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.染色质可及性:生物学功能、分子机制及治疗应用
Signal Transduct Target Ther. 2024 Dec 4;9(1):340. doi: 10.1038/s41392-024-02030-9.
7
Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease.细胞外基质成分和健康与疾病中的机械感知途径。
Biomolecules. 2024 Sep 20;14(9):1186. doi: 10.3390/biom14091186.
8
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.外源性 S1P 通过 S1P 受体 2 通过Src-RhoA-ROCK-YAP 通路诱导肝星状细胞中 CTGF 的表达。
Mol Biol Rep. 2024 Sep 2;51(1):950. doi: 10.1007/s11033-024-09868-w.
9
In Vitro Investigation of the Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol, Identified from Lam., on Hepatic Stellate Cells.从 Lam. 中鉴定出的 1-苯基-2-戊醇对肝星状细胞的抗纤维化作用的体外研究。
Int J Mol Sci. 2024 Aug 19;25(16):8995. doi: 10.3390/ijms25168995.
10
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils.IFN-α2 预处理 UC-MSCs 可通过募集中性粒细胞改善肝纤维化的治疗效果。
J Transl Med. 2023 Nov 18;21(1):832. doi: 10.1186/s12967-023-04732-0.
非选择性 Rho 激酶抑制剂 Y-27632 和 Y-33075 可降低鼠和人肝星状细胞的收缩,但增加其迁移。
PLoS One. 2023 Jan 31;18(1):e0270288. doi: 10.1371/journal.pone.0270288. eCollection 2023.
4
The role of glycans in the mechanobiology of cancer.糖链在癌症力学中的作用。
J Biol Chem. 2023 Mar;299(3):102935. doi: 10.1016/j.jbc.2023.102935. Epub 2023 Jan 21.
5
SRF/MRTF-A and liver cirrhosis: Pathologic associations.SRF/MRTF-A与肝硬化:病理关联
J Dig Dis. 2022 Nov;23(11):614-619. doi: 10.1111/1751-2980.13150. Epub 2023 Feb 7.
6
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence.溶血磷脂酸受体1(LPAR1)是细丝蛋白A的新型相互作用伴侣,可促进细丝蛋白A磷酸化、肌动蛋白调节因子A(MRTF-A)转录活性和癌基因诱导的衰老。
Oncogenesis. 2022 Dec 28;11(1):69. doi: 10.1038/s41389-022-00445-z.
7
Role of the Hippo pathway in liver regeneration and repair: recent advances.河马通路在肝脏再生与修复中的作用:最新进展
Inflamm Regen. 2022 Dec 5;42(1):59. doi: 10.1186/s41232-022-00235-5.
8
The Alterations and Roles of Glycosaminoglycans in Human Diseases.糖胺聚糖在人类疾病中的改变与作用
Polymers (Basel). 2022 Nov 18;14(22):5014. doi: 10.3390/polym14225014.
9
Jagged-1/Notch Pathway and Key Transient Markers Involved in Biliary Fibrosis during Infection.感染期间参与胆管纤维化的锯齿状蛋白-1/Notch信号通路及关键瞬时标志物
Trop Med Infect Dis. 2022 Nov 9;7(11):364. doi: 10.3390/tropicalmed7110364.
10
New insights into FAK structure and function in focal adhesions.在黏着斑中对 FAK 结构和功能的新认识。
J Cell Sci. 2022 Oct 15;135(20). doi: 10.1242/jcs.259089. Epub 2022 Oct 14.